These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35306659)

  • 1. Re-infection in COVID-19: Do we exaggerate our worries?
    Arslan Y; Akgul F; Sevim B; Varol ZS; Tekin S
    Eur J Clin Invest; 2022 Jun; 52(6):e13767. PubMed ID: 35306659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 re-infection risk in Austria.
    Pilz S; Chakeri A; Ioannidis JP; Richter L; Theiler-Schwetz V; Trummer C; Krause R; Allerberger F
    Eur J Clin Invest; 2021 Apr; 51(4):e13520. PubMed ID: 33583018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.
    Xia J; Zeng Y; Tan Z; Chen T; Hu W; Shuai S; Cao D; Zeng X
    AIDS Rev; 2021 Jun; 23(3):153-163. PubMed ID: 34082440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An outbreak of SARS-CoV-2 reinfection in a long-term care facility in South Korea.
    Kim IH; Shin M; Park AK; Song JS; Kim M; Park Y; Kim S; Cho HS; Jeong HM; Kim JM; Oh SJ; Kim JA; Lee CY; Lee JJ; Wang S; Rhee JE; Park YJ; Kim EJ
    J Infect Public Health; 2022 Sep; 15(9):966-969. PubMed ID: 35932619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 reinfections among naturally infected and vaccinated individuals.
    Rahman S; Rahman MM; Miah M; Begum MN; Sarmin M; Mahfuz M; Hossain ME; Rahman MZ; Chisti MJ; Ahmed T; Arifeen SE; Rahman M
    Sci Rep; 2022 Jan; 12(1):1438. PubMed ID: 35082344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Antibody Levels and SARS-Cov-2 Reinfection.
    Islamoglu MS; Cengiz M; Uysal BB; Ikitimur H; Ozdemir Z; Karamehmetoglu A; Akbulut AE; Bakdur AN; Ozdemir A; Kayıkcıoglu H; Ozdemir H; Uces R; Ersoy S; Yavuzer S
    Ann Clin Lab Sci; 2021 Nov; 51(6):750-755. PubMed ID: 34921027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, India.
    Madhavan R; Paul JS; Babji S; Kumar D; Prabhu SB; Pulleri HK; Annadorai R; Gowda SR; John J; Kang G
    BMJ Open; 2022 May; 12(5):e059869. PubMed ID: 35613771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of possible COVID-19 reinfection in children: A multicenter clinical study.
    Erbaş İC; Keleş YE; Erdeniz EH; Yılmaz AT; Yeşil E; Çakıcı Ö; Akça M; Ulu NK; Dinç F; Çiftdoğan DY; Öncel S; Kuyucu N; Tapısız A; Belet N
    Arch Pediatr; 2023 Apr; 30(3):187-191. PubMed ID: 36804354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
    Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
    Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Ann Intern Med; 2022 May; 175(5):674-681. PubMed ID: 35157493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Longitudinal Monitoring of Seroconversion Status in SARS-CoV-2 RT-PCR Positive Healthcare Workers].
    Ersoy L; Tezcan Ülger S; Gülbudak H; Yaşar N; Yapıcı G; Aslan G
    Mikrobiyol Bul; 2022 Jan; 56(1):114-123. PubMed ID: 35088965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinfection cases by closely related SARS-CoV-2 lineages in Southern Brazil.
    Gularte JS; da Silva MS; Demoliner M; Hansen AW; Heldt FH; Silveira F; Filippi M; Pereira VMAG; da Silva FP; Mallmann L; Fink P; Laux JL; Weber MN; de Almeida PR; Fleck JD; Spilki FR
    Braz J Microbiol; 2021 Dec; 52(4):1881-1885. PubMed ID: 34562232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
    Bozio CH; Grannis SJ; Naleway AL; Ong TC; Butterfield KA; DeSilva MB; Natarajan K; Yang DH; Rao S; Klein NP; Irving SA; Dixon BE; Dascomb K; Liao IC; Reynolds S; McEvoy C; Han J; Reese SE; Lewis N; Fadel WF; Grisel N; Murthy K; Ferdinands J; Kharbanda AB; Mitchell PK; Goddard K; Embi PJ; Arndorfer J; Raiyani C; Patel P; Rowley EA; Fireman B; Valvi NR; Griggs EP; Levy ME; Zerbo O; Porter RM; Birch RJ; Blanton L; Ball SW; Steffens A; Olson N; Williams J; Dickerson M; McMorrow M; Schrag SJ; Verani JR; Fry AM; Azziz-Baumgartner E; Barron M; Gaglani M; Thompson MG; Stenehjem E
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1539-1544. PubMed ID: 34735425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination - Kentucky, May-June 2021.
    Cavanaugh AM; Spicer KB; Thoroughman D; Glick C; Winter K
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1081-1083. PubMed ID: 34383732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.